The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening

A general model for evaluation of colorectal cancer screening has been implemented in the microsimulation program MISCAN-COLON. A large number of fictitious individual life histories are simulated in each of which several colorectal lesions can emerge. Next, screening for colorectal cancer is simulated, which will change some of the life histories. The demographic characteristics, the epidemiology and natural history of the disease, and the characteristics of screening are defined in the input. All kinds of assumptions on the natural history of colorectal cancer and screening and surveillance strategies can easily be incorporated in the model. MISCAN-COLON gives detailed output of incidence, prevalence and mortality, and the results and effects of screening. It can be used to test hypotheses about the natural history of colorectal cancer, such as the duration of progressive adenomas, and screening characteristics, such as sensitivity of tests, against empirical data. In decision making about screening, the model can be used for evaluation of screening policies, and for choosing between competing policies by comparing their simulated incremental costs and effectiveness outcomes.

[1]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[2]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[3]  Pierre L'Ecuyer,et al.  Implementing a random number package with splitting facilities , 1991, TOMS.

[4]  Averill M. Law,et al.  Simulation Modeling and Analysis , 1982 .

[5]  László Tabár,et al.  Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials , 1995 .

[6]  Harry J. de Koning,et al.  The impact of a breast cancer screening programme on quality‐adjusted life‐years , 1991, International journal of cancer.

[7]  J D Habbema,et al.  The MISCAN simulation program for the evaluation of screening for disease. , 1985, Computer methods and programs in biomedicine.

[8]  J D Habbema,et al.  Cervical‐cancer screening: Attendance and cost‐effectiveness , 1990, International journal of cancer.

[9]  J D Habbema,et al.  Modelling issues in cancer screening , 1995, Statistical methods in medical research.

[10]  J D Habbema,et al.  A model for breast cancer screening , 1990, Cancer.

[11]  D. Eddy,et al.  Screening for colorectal cancer , 1992, The Lancet.

[12]  M A Koopmanschap,et al.  Economic aspects of cervical cancer screening. , 1990, Social science & medicine.

[13]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[14]  J. Habbema,et al.  Predicting mortality from cervical cancer after negative smear test results. , 1992 .

[15]  J. Wolfowitz,et al.  Introduction to the Theory of Statistics. , 1951 .

[16]  F T Bosman,et al.  Prevention of colorectal cancer. Costs and effectiveness of sigmoidoscopy. , 1997, Scandinavian journal of gastroenterology. Supplement.

[17]  H. D. de Koning,et al.  Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors , 1991, International journal of cancer.

[18]  C. Mulrow,et al.  Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.

[19]  HJ de Koning,et al.  Breast cancer screening: its impact on clinical medicine , 1990, British Journal of Cancer.

[20]  J. Habbema,et al.  Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness. , 1997, British Journal of Cancer.

[21]  J. Habbema,et al.  Preventive Pap-smears: balancing costs, risks and benefits. , 1992, British Journal of Cancer.

[22]  J D Habbema,et al.  Review papers : Statistical models for estimating prevalence and incidence of parasitic diseases , 1993, Statistical methods in medical research.

[23]  J. Habbema,et al.  The cost‐effectiveness of breast cancer screening , 1989, International journal of cancer.

[24]  J. Habbema,et al.  Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. , 1991, British Journal of Cancer.

[25]  F. Macrae,et al.  Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. , 1982, Gastroenterology.

[26]  J D Habbema,et al.  Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears. , 1995, International journal of epidemiology.

[27]  E T Stewart,et al.  Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. , 1993, The New England journal of medicine.

[28]  J D Habbema,et al.  Model building on the basis of Dutch cervical cancer screening data. , 1985, Maturitas.

[29]  J. Habbema,et al.  A model‐based analysis of the hip project for breast cancer screening , 1990, International journal of cancer.

[30]  R Levine,et al.  Prevention and early detection of colorectal cancer. , 1992, American family physician.